ONCOLYTICS BIOTECH INC. Adjustments For Increase Decrease In Other Operating Payables
ONCOLYTICS BIOTECH INC. (ONCY) reported Adjustments For Increase Decrease In Other Operating Payables of CAD 1.29 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-07.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables · last filed 2025-03-07
| Period end | Adjustments For Increase Decrease In Other Operating Payables 12 month | Adjustments For Increase Decrease In Other Operating Payables 12 month as first filed |
|---|---|---|
| 2024-12-31 | 1.29M CAD 20-F · filed 2025-03-07 | |
| 2023-12-31 | 332.00K CAD 20-F · filed 2025-03-07 | |
| 2022-12-31 | -352.00K CAD 20-F · filed 2025-03-07 | |
| 2021-12-31 | 228.00K CAD 20-F · filed 2024-03-12 | 228.29K CAD 20-F · filed 2022-03-03 |
| 2020-12-31 | -723.00K CAD 20-F · filed 2023-03-03 | -723.23K CAD 20-F · filed 2021-03-05 |
| 2019-12-31 | 807.88K CAD 20-F · filed 2022-03-03 | |
| 2018-12-31 | -27.98K CAD 20-F · filed 2021-03-05 | |
| 2017-12-31 | 0.00 CAD 20-F · filed 2020-03-06 | 6.18M CAD 20-F · filed 2018-03-19 |
| 2016-12-31 | 0.00 CAD 20-F · filed 2019-03-15 | |
| 2015-12-31 | 0.00 CAD 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |